THE ADVANTAGE OF EARLY INTERVENTION BY TOCILIZUMAB FOR RHEUMATOID ARTHRITIS - FULL ANALYSIS OF ALL-CASE POSTMARKETING SURVEILLANCE IN 7,901 PATIENTS IN JAPAN

被引：0
|
作者：
Yamanaka, H. [1 ]
Harigai, M. [2 ]
Inokuma, S. [3 ]
Ishiguro, N. [4 ,5 ]
Ryu, J. [6 ]
Takei, S. [7 ]
Takeuchi, T. [8 ]
Tanaka, Y. [9 ]
Sano, Y. [10 ]
Koike, T. [11 ]
机构：
[1] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Tokyo, Japan
[3] Japanese Red Cross Med Ctr, Tokyo, Japan
[4] Nagoya Univ, Grad Sch, Nagoya, Aichi 4648601, Japan
[5] Nagoya Univ, Fac Med, Nagoya, Aichi 4648601, Japan
[6] Nihon Univ Sch Med, Tokyo, Japan
[7] Kagoshima Univ, Sch Hlth Sci, Kagoshima 890, Japan
[8] Keio Univ Sch Med, Tokyo, Japan
[9] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan
[10] Chugai Pharmaceut Co Ltd, Tokyo, Japan
[11] Sapporo Med Ctr NTT EC, Sapporo, Hokkaido, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2057
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 24 条
  • [1] Postmarketing Surveillance of Tocilizumab for Rheumatoid Arthritis In Japan-Full Analysis Report of 7,901 Patients.
    Yamanaka, Hisashi
    Harigai, Masayoshi
    Inokuma, Shigeko
    Ishiguro, Naoki
    Ryu, Junnosuke
    Takei, Syuji
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Sano, Youko
    Koike, Takao
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S1033 - S1033
  • [2] Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
    Koike, Takao
    Harigai, Masayoshi
    Inokuma, Shigeko
    Ishiguro, Naoki
    Ryu, Junnosuke
    Takeuchi, Tsutomu
    Takei, Syuji
    Tanaka, Yoshiya
    Ito, Kyoko
    Yamanaka, Hisashi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (12) : 2148 - 2151
  • [3] Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
    Koike, Takao
    Harigai, Masayoshi
    Inokuma, Shigeko
    Ishiguro, Naolci
    Ryu, Junnosuke
    Takeuchi, Tsutomu
    Takei, Syuji
    Tanaka, Yoshiya
    Sano, Yoko
    Yaguramaki, Hitomi
    Yamanaka, Hisashi
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (01) : 15 - 23
  • [4] SAFETY AND EFFECTIVENESS OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: 24-WEEK DATA OF ALL-CASE POSTMARKETING SURVEILLANCE IN CLINICAL USE IN JAPAN
    Pile, Kevin
    Tamura, Naoto
    Atsumi, Tatsuya
    Okamoto, Nami
    Takahashi, Nobunori
    Nakajima, Atsuo
    Nakajima, Ayako
    Fujii, Takao
    Matsuno, Hiroaki
    Tsujimoto, Naoto
    Nishikawa, Atsushi
    Ishii, Taeko
    Takeuchi, Tsutomu
    Kuwana, Masataka
    Takagi, Michiaki
    [J]. INTERNAL MEDICINE JOURNAL, 2022, 52 : 30 - 30
  • [5] CHARACTERISTICS ASSOCIATED WITH BETTER EFFECTIVENESS AND SAFETY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INTRAVENOUS TOCILIZUMAB: RESULTS FROM FULL ANALYSIS OF ALL-PATIENT POSTMARKETING SURVEILLANCE IN JAPAN
    Harigai, M.
    Inokuma, S.
    Ishiguro, N.
    Ryu, J.
    Takeuchi, T.
    Takei, S.
    Tanaka, Y.
    Yamanaka, H.
    Sano, Y.
    Yaguramaki, H.
    Koike, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 621 - 621
  • [6] AN INTERIM ANALYSIS OF ALL-CASE POSTMARKETING SURVEILLANCE OF TAFAMIDIS MEGLUMINE FOR PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS AND PATIENT PROFILE IN JAPAN
    Hirano, Y.
    Ishii, T.
    Matsumoto, N.
    Takata, A.
    Sekijima, Y.
    Ueda, M.
    Ando, Y.
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S12 - S12
  • [7] Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
    Okamoto, Nami
    Atsumi, Tatsuya
    Takagi, Michiaki
    Takahashi, Nobunori
    Takeuchi, Tsutomu
    Tamura, Naoto
    Nakajima, Atsuo
    Nakajima, Ayako
    Fujii, Takao
    Matsuno, Hiroaki
    Ishii, Taeko
    Tsujimoto, Naoto
    Nishikawa, Atsushi
    Minatoya, Machiko
    Tanaka, Yoshiya
    Kuwana, Masataka
    [J]. MODERN RHEUMATOLOGY, 2024,
  • [8] Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance
    Ishii, Tomonori
    Hirano, Yoko
    Matsumoto, Noriko
    Takata, Ami
    Sekijima, Yoshiki
    Ueda, Mitsuharu
    Ando, Yukio
    [J]. CLINICAL THERAPEUTICS, 2020, 42 (09) : 1728 - +
  • [9] Longterm safety of tocilizumab: Results from 3 years of followup postmarketing surveillance of 5573 patients with rheumatoid arthritis in Japan
    Yamamoto, Kazuhiko
    Goto, Hajime
    Hirao, Kenzo
    Nakajima, Atsuo
    Origasa, Hideki
    Tanaka, Kunihiko
    Tomobe, Minako
    Totsuka, Kyoichi
    [J]. Applied and Environmental Microbiology, 2019, 85 (08) : 1368 - 1375
  • [10] Longterm Safety of Tocilizumab: Results from 3 Years of Followup Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan
    Yamamoto, Kazuhiko
    Goto, Hajime
    Hirao, Kenzo
    Nakajima, Atsuo
    Origasa, Hideki
    Tanaka, Kunihiko
    Tomobe, Minako
    Totsuka, Kyoichi
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (08) : 1368 - 1375
123